Immediate Impact
3 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Works of Ivan Sinielnikov being referenced
MO01.42 Myelopreservation with Trilaciclib Regardless of Risk of Chemotherapy-Induced Febrile Neutropenia and/or Anemia or Red Blood Cell Transfusions
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ivan Sinielnikov | 13 | 3 | 6 | 7 | 4 | 19 | |
| Farzaana Adam | 14 | 2 | 4 | 4 | 3 | 21 | |
| A Somfay | 12 | 3 | 8 | 8 | 4 | 21 | |
| Donald Richards | 12 | 4 | 5 | 12 | 5 | 21 | |
| S. Dubinett | 6 | 2 | 8 | 6 | 5 | 22 | |
| Gloryanne Aidoo-Micah | 7 | 2 | 5 | 8 | 3 | 18 | |
| HarveyM. Golomb | 7 | 2 | 7 | 4 | 4 | 19 | |
| Arnaud Sandrin | 6 | 2 | 4 | 4 | 3 | 20 | |
| Prashanthi Natarajan | 11 | 3 | 9 | 5 | 3 | 18 | |
| Till Wallrabenstein | 20 | 2 | 11 | 4 | 4 | 25 | |
| Marivic Ricamara | 10 | 2 | 4 | 8 | 2 | 16 |
All Works
Loading papers...